Form 4 · Filed Jun 2, 2026, 08:25 PM UTC
ASND/Ascendis Pharma A/S
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | P | buy | 100 | $219 | $21,900 | 4,367 |
Source: SEC EDGAR raw filing ↗ · Accession 0001610717-26-000179